With the combination of both drugs, we observed a significant trend toward upregulation of proapoptotic genes DIABLO , NOXA , BAX , FAS , and DR4 , and downregulation of the antiapoptotic genes BCL-XL and SURVIVIN .
← all excerpts
Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.
1
—
—